Hideaki Tahara

11.4k total citations · 1 hit paper
172 papers, 9.0k citations indexed

About

Hideaki Tahara is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hideaki Tahara has authored 172 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Immunology, 62 papers in Oncology and 55 papers in Molecular Biology. Recurrent topics in Hideaki Tahara's work include Immunotherapy and Immune Responses (57 papers), Immune Cell Function and Interaction (45 papers) and Virus-based gene therapy research (37 papers). Hideaki Tahara is often cited by papers focused on Immunotherapy and Immune Responses (57 papers), Immune Cell Function and Interaction (45 papers) and Virus-based gene therapy research (37 papers). Hideaki Tahara collaborates with scholars based in Japan, United States and Russia. Hideaki Tahara's co-authors include Paul D. Robbins, Michael T. Lotze, Walter J. Storkus, Laurence Zitvogel, Robert D. Schreiber, Hitoshi Shiozaki, S F Wolf, Howard Edington, Takuya Tsunoda and Michael A. Nalesnik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Hideaki Tahara

166 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant IL-12 administration induces tumor regression in association with IFN- gamma production.

1994 672 citations Hideaki Tahara et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideaki Tahara Japan	51	5.1k	3.6k	3.5k	1.9k	895	172	9.0k
Linda Muul United States	29	5.2k 1.0×	3.0k 0.8×	4.1k 1.2×	2.3k 1.2×	1.0k 1.1×	51	10.4k
Catia Traversari Italy	46	8.3k 1.6×	5.5k 1.5×	5.5k 1.6×	2.2k 1.2×	493 0.6×	109	12.7k
Christoph Huber Germany	45	5.0k 1.0×	3.3k 0.9×	3.5k 1.0×	904 0.5×	343 0.4×	155	8.6k
Chrystal M. Paulos United States	39	5.5k 1.1×	2.3k 0.6×	5.4k 1.6×	1.1k 0.6×	340 0.4×	132	9.2k
Thomas Wirth Germany	44	2.1k 0.4×	2.5k 0.7×	1.6k 0.5×	1.1k 0.6×	841 0.9×	178	6.3k
Chiara Castelli Italy	46	5.8k 1.1×	4.4k 1.2×	4.8k 1.4×	488 0.3×	370 0.4×	127	10.2k
Mirella Giovarelli Italy	45	4.0k 0.8×	1.8k 0.5×	2.2k 0.6×	826 0.4×	308 0.3×	148	6.3k
Walter J. Storkus United States	66	12.9k 2.5×	5.6k 1.6×	6.3k 1.8×	1.9k 1.0×	259 0.3×	249	16.3k
Amnon Peled Israel	49	4.7k 0.9×	2.9k 0.8×	4.7k 1.4×	481 0.3×	653 0.7×	138	10.3k
Luca Gattinoni United States	55	10.8k 2.1×	4.1k 1.2×	10.5k 3.0×	2.5k 1.3×	302 0.3×	101	16.1k

Countries citing papers authored by Hideaki Tahara

Since Specialization

Citations

This map shows the geographic impact of Hideaki Tahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Tahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Tahara more than expected).

Fields of papers citing papers by Hideaki Tahara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Tahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Tahara. The network helps show where Hideaki Tahara may publish in the future.

Co-authorship network of co-authors of Hideaki Tahara

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Tahara. A scholar is included among the top collaborators of Hideaki Tahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Tahara. Hideaki Tahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wada, Hiroshi, Shinichiro Hasegawa, Kei Asukai, et al.. (2024). Prediction for oxaliplatin‐induced liver injury using patient‐derived liver organoids. Cancer Medicine. 13(3). e7042–e7042. 5 indexed citations

Inoue, Takako, Takashi Akazawa, Kei Kunimasa, et al.. (2024). Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG‐E8. Cancer Science. 115(4). 1114–1128. 3 indexed citations

Harada, Yoichiro, Takehiro Suzuki, Akiyoshi Hirayama, et al.. (2023). Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells. eLife. 12. 9 indexed citations

Yokoyama, Satoru, et al.. (2022). GSTA4 Governs Melanoma Immune Resistance and Metastasis. Molecular Cancer Research. 21(1). 76–85. 1 indexed citations

Uruno, Takehito, Yuki Sugiura, Daiji Sakata, et al.. (2022). Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells. International Immunology. 34(5). 277–289. 16 indexed citations

Yamamoto, Seiji, Takashi Hori, Masakiyo Sasahara, et al.. (2018). NK Cells Control Tumor-Promoting Function of Neutrophils in Mice. Cancer Immunology Research. 6(3). 348–357. 47 indexed citations

Kaneko, Mika K., Shinji Abe, Satoshi Ogasawara, et al.. (2017). Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(1). 25–29. 17 indexed citations

Kato, Yukinari, Akiko Kunita, Masashi Fukayama, et al.. (2017). Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(1). 20–24. 24 indexed citations

Ma, Zhifeng, Wen Li, Shinichi Yoshiya, et al.. (2016). Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18. Clinical Cancer Research. 22(12). 2969–2980. 77 indexed citations

10.

Baba, Toshiyuki, Akihiko Itoh, Naoki Oyaizu, et al.. (2010). Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402. Journal of Translational Medicine. 8(1). 84–84. 21 indexed citations

11.

Itoh, Akihiko, et al.. (2010). A CASE OF COLORECTAL CANCER WITH MULTIPLE CUTANEOUS AND SUBCUTANEOUS METASTASES. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 71(9). 2394–2397.

12.

Ishizaki, Hidenobu, Takuya Tsunoda, Satoshi Wada, Masabumi Shibuya, & Hideaki Tahara. (2006). Development of anti-angiogenic cancer vaccine using epitope peptides derived from vascular endothelial growth factor receptor 1 (VEGFR1). Cancer Research. 66. 331–331. 1 indexed citations

13.

Higuchi, Noboru, Hiroki Maruyama, Takeshi Kuroda, et al.. (2003). Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar–Kyoto rats. Gene Therapy. 10(16). 1297–1310. 31 indexed citations

14.

Oikawa, Yoichi, Akira Shimada, Akira Kasuga, et al.. (2003). Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice. The Journal of Immunology. 171(11). 5865–5875. 66 indexed citations

15.

Kimura, Yu, et al.. (2003). Effects of Combined Therapy With Interleukin 2 and Interleukin 12 Gene–Transfected Tumor Vaccine for Head and Neck Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 129(11). 1181–1181. 6 indexed citations

16.

Qin, Lihui, Yaozhong Ding, Hideaki Tahara, & Jonathan S. Bromberg. (2001). Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft. The Journal of Immunology. 166(4). 2385–2393. 20 indexed citations

17.

Takayama, Takuya, Hideaki Tahara, & Angus W. Thomson. (1999). TRANSDUCTION OF DENDRITIC CELL PROGENITORS WITH A RETROVIRAL VECTOR ENCODING VIRAL INTERLEUKIN-10 AND ENHANCED GREEN FLUORESCENT PROTEIN ALLOWS PURIFICATION OF POTENTIALLY TOLEROGENIC ANTIGEN-PRESENTING CELLS1,2. Transplantation. 68(12). 1903–1909. 30 indexed citations

18.

Couderc, Bettina, Laurence Zitvogel, Victorine Douin‐Echinard, et al.. (1998). Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.. PubMed. 5(3). 163–75. 69 indexed citations

19.

Shiozaki, Hitoshi, Hideaki Tahara, Hiroshi Oka, et al.. (1991). Expression of immunoreactive E-cadherin adhesion molecules in human cancers.. PubMed Central. 139(1). 17–23. 341 indexed citations

20.

Noguchi, Shinzaburo, Hideaki Tahara, Keisuke Miyauchi, & Hiroki Koyama. (1989). Influence of 1α,25-Dihydroxy vitamin D<sub>3</sub> on the Development and Steroid Hormone Receptor Contents of DMBA-Induced Rat Mammary Tumors. Oncology. 46(4). 273–276. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact